Childhood cancer survivors show sustained benefit from common ADHD medication

A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behaviour changes that affect many childhood cancer survivors, according to a multicentre trial led by St. Jude Children's Research Hospital investigators...

Read the whole article on

More from